Viewing Study NCT03911102


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-02-21 @ 11:35 PM
Study NCT ID: NCT03911102
Status: COMPLETED
Last Update Posted: 2023-06-27
First Post: 2019-03-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
Sponsor: Revance Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lateral Canthal Lines View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lateral canthal wrinkle View
None Crow's feet lines View
None LCL View